Indeed, myeloid cells associated with a favourable clinical response expressed transcripts associated with tumour-residing CCR7+ DCs, including CCR7, CD274, IL15, PVR and CD70 (Fig. 6e). This evidence concerns the gene CD70 and neoplasm.